ロード中...
Germline single nucleotide polymorphisms in ERBB3 and BARD1 genes result in a worse relapse free survival response for HER2-positive breast cancer patients treated with adjuvant based docetaxel, carboplatin and trastuzumab (TCH)
Breast cancer is the leading cause of cancer related deaths in women worldwide and is classified into subtypes based on the cancer’s receptor status. Of these subtypes, those expressing the human epidermal growth factor receptor 2 (HER2) receptor were traditionally associated with poor prognosis. Se...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6071997/ https://ncbi.nlm.nih.gov/pubmed/30071039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0200996 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|